Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.66    0.06 (2.31%)
Bid:
2.625
Ask:
2.665
Spread: 0.04 (1.524%)
Market Cap: $8.78b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

3rd Quarter Results - Consolidated

3 Nov 2023 07:05

RNS Number : 2563S
Commercial Intnl Bank (Egypt) SAE
03 November 2023
Β 

Commercial International Bank (Egypt) S.A.E.

Consolidated Financial Statements

Β 

September 30, 2023

Β 

Β 

Β 

Condensed Consolidated Interim Statement of Financial Position as at September 30, 2023

Β 

Notes

Sep. 30, 2023

Β 

Dec. 31, 2022

Β 

EGP Thousands

Β 

EGP Thousands

Β 

Assets

Β 

Β 

Β 

Cash and balances at the central bank

8

59,950,223

Β 

47,492,549

Β 

Due from banks

9

276,842,860

Β 

133,856,720

Β 

Loans and advances to banks, net

11

-

Β 

2,978,197

Β 

Loans and advances to customers, net

12

223,085,568

Β 

193,599,872

Β 

Derivative financial instruments

Β 

1,647,485

Β 

1,939,961

Β 

Financial investments

Β 

Β 

Β 

- Financial Assets at Fair Value through OCI

13

189,098,612

Β 

204,020,733

Β 

- Financial Assets at Amortized cost

13

39,177,670

Β 

34,524,760

Β 

- Investments in associates

14

132,476

Β 

186,062

Β 

Non current assets held for sale

29

214

Β 

-

Β 

Other assets

15

17,375,013

Β 

14,521,427

Β 

Goodwill

26

65,325

Β 

96,268

Β 

Intangible assets

27

-

Β 

24,188

Β 

Deferred tax assets

Β 

1,137,342

Β 

185,746

Β 

Property and equipment

16

2,556,198

Β 

2,405,434

Β 

Total assets

Β 

811,068,986

Β 

635,831,917

Β 

Liabilities and equity

Β 

Β 

Β 

Liabilities

Β 

Β 

Β 

Due to banks

17

19,022,706

Β 

3,496,698

Β 

Due to customers

18

667,669,213

Β 

531,616,550

Β 

Non current liabilities held for sale

30

933

Β 

-

Β 

Derivative financial instruments

Β 

99,911

Β 

219,752

Β 

Current income tax liabilities

6,993,454

Β 

3,051,583

Β 

Other liabilities

19

15,875,568

Β 

11,606,912

Β 

Issued debt instruments

20

3,071,834

Β 

2,456,607

Β 

Other loans

Β 

10,387,714

Β 

7,978,975

Β 

Other provisions

21

10,511,982

Β 

7,066,672

Β 

Total liabilities

Β 

733,633,315

Β 

567,493,749

Β 

Equity

Β 

Β 

Β 

Β 

Issued and paid up capital

Β 

30,195,010

Β 

29,825,134

Β 

Reserves

Β 

23,007,690

Β 

19,643,327

Β 

Reserve for employee stock ownership plan (ESOP)

Β 

1,339,443

Β 

1,895,435

Β 

Retained earnings *

22,764,552

Β 

16,393,841

Β 

Total equity and net profit for the period / year

77,306,695

67,757,737

Non Controlling Interest

Β 

128,976

Β 

580,431

Β 

Total minority interest, equity and net profit for the period / year

77,435,671

68,338,168

Β 

Total liabilities and equity

811,068,986

635,831,917

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

The accompanying notes are an integral part of these financial statements .

Β 

Β 

(Limited review report attached)

* Including net profit for the current period

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Hussein Abaza

Hisham Ezz Al-Arab

Β 

CEO & Managing Director

Chairman

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Income Statement for the period ended September 30, 2023

Β 

Β 

Β 

Β 

Β 

Β 

Last 9 Months

Β 

Last 9 Months

Notes

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Interest and similar income

73,006,422

Β 

38,938,124

Interest and similar expense

(35,275,583)

Β 

(17,120,373)

Net interest income

Β 

37,730,839

Β 

21,817,751

Β 

Β 

Fee and commission income

6,543,585

Β 

3,908,463

Fee and commission expense

(2,589,680)

Β 

(1,730,281)

Net fee and commission income

Β 

3,953,905

Β 

2,178,182

Β 

Β 

Dividend income

83,653

Β 

54,557

Net trading income

5

3,165,144

Β 

1,434,169

Profits (Losses) on financial investments

13.1

165,478

Β 

1,096,850

Administrative expenses

(6,501,663)

Β 

(5,142,060)

Other operating (expenses) income

6

(5,679,447)

Β 

(3,404,237)

Goodwill amortization

26

(30,943)

Β 

(30,943)

Intangible assets amortization

27

(24,188)

Β 

(7,774)

Impairment release (charges) for credit losses

(1,216,770)

Β 

(298,078)

Bank's share in the profits / losses of associates

(39,486)

Β 

(16,343)

Profit before income tax

Β 

31,606,522

Β 

17,682,074

Β 

Β 

Income tax expense

28

(9,540,412)

Β 

(4,885,951)

Deferred tax assets (Liabilities)

28

392,680

Β 

(597,241)

Net profit from continued operations

Β 

22,458,790

Β 

12,198,882

Β 

Β 

Discontinued Operations

Β 

Β 

Β 

Net profit (loss) from discontinued operations

31

(49,699)

Β 

-

Net profit for the period

Β 

22,409,091

Β 

12,198,882

Β 

Β 

Non Controlling Interest

3,328

Β 

25,625

Bank's shareholders

Β 

22,405,763

Β 

12,173,257

Β 

Β 

Earnings per share

7

Β 

Β 

Basic

6.41

Β 

3.62

Diluted

6.34

Β 

3.58

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim statement of Comprehensive Income for the period ended September 30, 2023

Β 

Last 9 Months

Β 

Last 9 Months

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Net profit for the period

22,409,091

Β 

12,198,882

Β 

Β 

Change in fair value of Financial invesments measured at fair value through comprehensive income after tax

(9,629,911)

Β 

(13,184,005)

Transferred to RE from financial assets at fair value through comprehensive income

(95,308)

Β 

(4,128)

Cumulative foreign currencies translation differences

193,162

Β 

96,867

Effect of ECL in fair value of debt instruments measured at fair value through comprehensive income

201,185

Β 

233,717

Total comprehensive income for the period

Β 

13,078,219

Β 

(658,667)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

As follows:

Bank's shareholders

13,074,891

Β 

(684,292)

Non-Controlling Interest

3,328

Β 

25,625

Total comprehensive income for the period

Β 

13,078,219

Β 

(658,667)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Cash flows for the period ended September 30 2023

Β 

Β 

Notes

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Cash flow from operating activities

Β 

Β 

Β 

Profit before income tax from continued operations

31,606,522

Β 

17,682,074

Profit (loss) from discontinued operations

(49,699)

Β 

-

Adjustments to reconcile profits to net cash provided by operating activities

Β 

Β 

Β 

Fixed assets depreciation

16

655,051

Β 

644,401

Impairment (Released) charge for credit losses (Loans and advances to customers and banks)

1,050,980

Β 

12,998

Other provisions charges

21

2,350,253

Β 

1,803,568

Impairment (Released) charge for credit losses (due from banks)

(47,249)

Β 

534

Impairment (Released) charge for credit losses (financial investments)

213,039

Β 

284,546

Impairment (Released) charge for other assets

14,347

Β 

(277,768)

Exchange revaluation differences for financial assets at fair value through OCI and AC

(5,409,592)

Β 

(3,745,045)

Goodwill amortization

26

30,943

Β 

30,943

Intangible assets amortization

27

24,188

Β 

7,774

Utilization of other provisions

21

(1,608)

Β 

(1,857)

Other provisions no longer used

21

-

Β 

(101)

Exchange Revaluation differences of other provisions

21

1,096,665

Β 

333,425

profits from selling property and equipment

(194)

Β 

(2,192)

profits from selling financial investments at fair value through OCI

13.1

(149,012)

Β 

(1,096,850)

Losses (Profits) from selling investments in associates

13.1

(7,466)

Β 

-

Impairment (Released) charges of investments in associates

13.1

(9,000)

Β 

-

Shares based payments

608,250

Β 

579,653

Bank's share in the profits / losses of associates

39,486

Β 

16,343

Operating profits before changes in operating assets and liabilities

Β 

32,015,904

Β 

16,272,446

Β 

Β 

Net decrease / increase in assets and liabilities

Β 

Β 

Β 

Due from banks

9,859,636

Β 

870,167

Financial assets at fair value through P&L

-

Β 

240,987

Derivative financial instruments

172,635

Β 

(947,321)

Loans and advances to banks and customers

11 - 12

(27,548,758)

Β 

(33,780,208)

Other assets

(2,506,019)

Β 

1,245,185

Non current assets held for sale

(214)

Β 

-

Due to banks

17

15,526,008

Β 

881,371

Due to customers

18

136,052,663

Β 

91,778,069

Current income tax obligations paid

(2,546,958)

Β 

(2,207,579)

Non current liabilities held for sale

933

Β 

-

Other liabilities

(3,890,097)

Β 

(325,379)

Net cash generated from (used in) operating activities

Β 

157,135,733

Β 

74,027,738

Β 

Β 

Cash flow from investing activities

Β 

Β 

Β 

Proceeds from Investments in associates.

2,119

Β 

-

Payment for purchases of property, equipment and branches construction

(1,177,450)

Β 

(556,512)

Proceeds from selling property and equipment

194

Β 

2,192

Proceeds from redemption of financial assets at amortized cost

5,278,030

Β 

6,520,697

Payment for purchases of financial assets at amortized cost

(9,334,085)

Β 

(18,268,602)

Payment for purchases of financial assets at fair value through OCI

(64,860,157)

Β 

(115,077,815)

Proceeds from selling financial assets at fair value through OCI

75,128,566

Β 

73,424,845

Payment for investment in subsidiaries.

(1,008,761)

Β 

-

Net cash generated from (used in) investing activities

Β 

4,028,456

Β 

(53,955,195)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim Cash flows for the period ended September 30, 2023 (Cont.)

Β 

Β 

Sep. 30, 2023

Β 

Sep. 30, 2022

EGP Thousands

Β 

EGP Thousands

Β 

Β 

Cash flow from financing activities

Β 

Β 

Β 

Other loans

2,408,739

Β 

1,116,344

Dividends paid

(3,594,747)

Β 

(4,410,322)

Issued debt instruments

615,227

Β 

382,977

Capital increase

369,876

Β 

122,716

Net cash generated from (used in) financing activities

Β 

(200,905)

Β 

(2,788,285)

Β 

Β 

Β 

Β 

Β 

Net (decrease) increase in cash and cash equivalent during the period

160,963,284

Β 

17,284,258

Beginning balance of cash and cash equivalent

92,969,526

Β 

61,065,822

Cash and cash equivalent at the end of the period

Β 

253,932,810

Β 

78,350,080

Β 

Β 

Β 

Cash and cash equivalent comprise:

Β 

Β 

Β 

Cash and balances at the central bank

59,950,223

Β 

43,857,708

Due from banks

276,845,003

Β 

90,499,843

Treasury bills

10

71,507,826

Β 

87,122,900

Obligatory reserve balance with CBE

(52,963,236)

Β 

(38,082,441)

Due from banks with maturity more than three months

(30,994,611)

Β 

(22,949,758)

Treasury bills with maturity more than three months

(70,412,395)

Β 

(82,098,172)

Total cash and cash equivalent

Β 

253,932,810

Β 

78,350,080

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Interim statement of changes in shareholders' equity

Β 

Sep. 30, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

Β 

EGP Thousands

Beginning Balance at 1 January 2022

19,702,418

3,293,074

28,260,532

1,550,906

8,183

16,000

641,372

9,141

13,696,402

1,674,392

(4,218)

68,848,202

454,535

69,302,737

Capital increase

10,122,716

-

(10,000,000)

-

-

-

-

-

-

-

-

122,716

-

122,716

Transferred to reserves

-

670,872

8,836,326

-

-

2,947

-

-

(9,007,223)

(502,922)

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(4,410,322)

-

-

(4,410,322)

-

(4,410,322)

Net profit for the period

-

-

-

-

-

-

-

-

12,173,257

-

-

12,173,257

25,625

12,198,882

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

(4,128)

-

4,128

-

-

-

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(13,184,005)

-

-

-

-

(13,184,005)

-

(13,184,005)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

2,840

(2,840)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

233,717

-

-

-

-

233,717

-

233,717

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

579,653

-

579,653

-

579,653

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

101,085

101,085

65,507

166,592

Balance at 30 September 2022

29,825,134

3,963,946

27,096,858

1,550,906

8,183

18,947

(12,313,044)

11,981

12,453,402

1,751,123

96,867

64,464,303

545,667

65,009,970

Β 

Β 

Β 

Β 

Sep. 30, 2023

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

Β 

EGP Thousands

Beginning Balance at 1 January 2023

29,825,134

3,963,946

27,096,858

1,550,906

8,183

18,947

(13,188,818)

11,981

16,393,841

1,895,435

181,324

67,757,737

580,431

68,338,168

Capital increase

369,876

-

-

-

-

-

-

-

-

-

-

369,876

-

369,876

Transferred to reserves

-

806,408

12,743,849

-

-

2,208

-

-

(12,388,223)

(1,164,242)

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(3,738,888)

-

-

(3,738,888)

(17,108)

(3,755,996)

Net profit for the period

-

-

-

-

-

-

-

-

22,405,763

-

-

22,405,763

3,328

22,409,091

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

(95,308)

-

95,308

-

-

-

-

-

Change in non controlling interest from acquisition of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

(536,867)

(536,867)

Reserve for transactions under common control

-

-

-

-

(679,155)

-

-

-

-

-

-

(679,155)

-

(679,155)

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(9,629,911)

-

-

-

-

(9,629,911)

-

(9,629,911)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

3,249

(3,249)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

201,185

-

-

-

-

201,185

-

201,185

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

608,250

-

608,250

-

608,250

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

11,838

11,838

99,192

111,030

Β Balance at 30 September 2023

30,195,010

4,770,354

39,840,707

1,550,906

(670,972)

21,155

(22,712,852)

15,230

22,764,552

1,339,443

193,162

77,306,695

128,976

77,435,671

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
QRTFSWFWEEDSEIF
Date   Source Headline
12th Nov 20217:00 amRNSCIB 3Q21 Separate Condensed Financial Results
12th Nov 20217:00 amRNSCIB 3Q21 Earnings Release
13th Jul 20217:00 amRNSCIB1H2021 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB 1H2021 Condensed Separate Financial Results
13th Jul 20217:00 amRNSCIB1H2021 Earnings Release
24th Jun 20213:43 pmRNSRelease re the change of title of Mr.Hussein Abaza
24th May 20217:00 amRNSCIB 1st Quarter Consolidated Financial Results
24th May 20217:00 amRNSCIB 1Q2021 Earnings Release
24th May 20217:00 amRNSCIB 1st Quarter Separate Financial Results
29th Apr 202110:09 amRNSCIB FY2020 Annual Financial Report
31st Mar 20215:28 pmRNSResolutions of CIB ordinary GAM held on March 30
8th Mar 20218:24 amRNSInvitation to CIB OrdinaryGeneral Assembly Meeting
8th Mar 20217:00 amRNSRelease regarding a change in CIB's BOD Structure
1st Mar 20217:00 amRNSCIB FY20 Year End Earnings Release
1st Mar 20217:00 amRNSCIB FY20 Consolidated Results
1st Mar 20217:00 amRNSCIB FY20 Year End Separate Financial Results
16th Dec 20207:00 amRNSCIB 3Q20 Earnings Release
16th Dec 20207:00 amRNSCIB 3rd Quarter Consolidated Condensed Results
16th Dec 20207:00 amRNSCIB 3rd Quarter Separate Condensed Results
16th Nov 20207:00 amRNSCIB Release on November 15th,2020
27th Oct 20202:28 pmRNSCIB's Press Release dated October 27th, 2020
23rd Oct 20203:59 pmRNSCIB Press Release
12th Oct 20204:13 pmRNSRelease concerning changes in CIB'sBoard Structure
22nd Sep 20202:33 pmRNSRelease on change in Board of Directors Structure
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSCIB First Half 2020 Earnings Release
14th Jul 20207:00 amRNSCIB Consolidated Interim Condensed June Statements
14th Jul 20207:00 amRNSCIB Interim Separate Condensed June Statements
1st Jul 20201:04 pmRNSRelease on Subordinated debt from CDC
5th May 20207:00 amRNSCIB reports 1Q20 Earning Release
5th May 20207:00 amRNSCIB 1st Quarter Consolidated Results
5th May 20207:00 amRNSCIB 1st Quarter Separate Results
28th Apr 20207:00 amRNSCIB Year End 2019 IFRS Consolidated Results
27th Apr 20207:00 amRNSCIB acquires 51% of Mayfair Bank in Kenya
30th Mar 20209:00 amRNSRelease on CEO self-quarantine
24th Mar 202012:02 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSCIB's AGM Resolutions (March 15th 2020)
16th Mar 20207:00 amRNSCIB's EGM Resolutions (March 15th 2020)
20th Feb 20202:39 pmRNSItems to be discussed in EGM of March 15th, 2020
20th Feb 20202:37 pmRNSItems to be discussed in AGM of March 15th, 2020
18th Feb 20202:31 pmRNSInvitation to CIB Extraordinary GAM
18th Feb 20202:29 pmRNSInvitation toCIB Ordinary General Assembly Meeting
4th Feb 20207:00 amRNSFY 2019 Separate Financial Results
4th Feb 20207:00 amRNSFY 2019 Consolidated Financial Results
4th Feb 20207:00 amRNSFY 2019 Earnings Release
5th Nov 20197:00 amRNSCIB 3Q 2019 Consolidated Financial Results
5th Nov 20197:00 amRNSCIB Separate 3rd Quarter Results
5th Nov 20197:00 amRNSCIB 3Q 2019 Earnings Release
9th Oct 20197:00 amRNSChanges in CIB's Board of Directors
9th Jul 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.